These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17160428)

  • 1. Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks.
    Kohl I; Nemecek V; Summerová M; Chlíbek R; Nad'ová K; Mináriková O
    Eur J Epidemiol; 2006; 21(12):893-9. PubMed ID: 17160428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community.
    Shen YG; Gu XJ; Zhou JH
    World J Gastroenterol; 2008 May; 14(17):2771-5. PubMed ID: 18461664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
    Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
    Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunisation during an outbreak of hepatitis A in a German day-care centre.
    Hauri AM; Fischer E; Fitzenberger J; Uphoff H; Koenig C
    Vaccine; 2006 Jul; 24(29-30):5684-9. PubMed ID: 16730103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J
    Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology and control of hepatitis A.
    Maguire H; Heptonstall J; Begg NT
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R114-7. PubMed ID: 1284926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the control of hepatitis A virus infection.
    Crowcroft NS; Walsh B; Davison KL; Gungabissoon U;
    Commun Dis Public Health; 2001 Sep; 4(3):213-27. PubMed ID: 11732363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.
    McMahon BJ; Beller M; Williams J; Schloss M; Tanttila H; Bulkow L
    Arch Pediatr Adolesc Med; 1996 Jul; 150(7):733-9. PubMed ID: 8673200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of an outbreak of hepatitis A in two villages by vaccination.
    Príkazský V; Oleár V; Cernoch A; Safary A; André FE
    J Med Virol; 1994 Dec; 44(4):457-9. PubMed ID: 7897381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine.
    Zamir C; Rishpon S; Zamir D; Leventhal A; Rimon N; Ben-Porath E
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):185-7. PubMed ID: 11347668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and control of hepatitis A.
    Drug Ther Bull; 1994 Feb; 32(2):9-11. PubMed ID: 7635017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.